King Pharmaceuticals KG Other run-off lines — Total Diversified Reinsurance adverse PPD
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by King Pharmaceuticals in its filing.
Tagged under the XBRL concept kg:LiabilityforUnpaidClaimsandClaimsAdjustmentExpensePeriodIncreaseDecreaseNetofCommissionChanges.
The official record: King Pharmaceuticals’s 10-K, filed March 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about King Pharmaceuticals's other run-off lines — total diversified reinsurance adverse ppd.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is King Pharmaceuticals's other run-off lines — total diversified reinsurance adverse PPD?
- King Pharmaceuticals (KG) reported other run-off lines — total diversified reinsurance adverse PPD of -$71.5K in Q4 2025.
- What does other run-off lines — total diversified reinsurance adverse PPD mean?
- This metric represents the unfavorable prior period development (PPD) associated with diversified reinsurance liabilities within the company's run-off insurance segment. It reflects adjustments made to loss reserves established in previous reporting periods due to changes in estimated ultimate claims costs. Monitoring this figure helps investors assess the adequacy of historical reserving practices and the potential for earnings volatility within discontinued or legacy business lines.